Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis - Toyama, T; Neuen, B L; Jun, M (Diabetes Obes Metab, 2019)
et al.